What is Oracea
DoxycyclineThe Generic name of this drug
Treatment SummaryDoxycycline is a type of antibiotic used to treat a wide range of bacterial infections. It is derived from oxytetracycline and is a second-generation tetracycline, meaning it has lower levels of toxicity than the first-generation of tetracyclines. The effectiveness of doxycycline in treating an infection depends on the results of an antibiotic susceptibility test.
Vibramycin Hyclateis the brand name
Oracea Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Vibramycin Hyclate
Doxycycline
1967
728
Approved as Treatment by the FDA
Doxycycline, otherwise known as Vibramycin Hyclate, is approved by the FDA for 1 uses such as Brucellosis .Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Effectiveness
How Oracea Affects PatientsDoxycycline is an antibiotic that helps stop the growth of bacteria, and works by preventing bacteria from making proteins. It is a lipophilic drug, meaning it can pass through multiple layers of cells, and has a wide range of effectiveness against both gram-positive and gram-negative bacteria. It also has anti-parasitic and anti-inflammatory properties, and has been used to treat various inflammatory skin conditions.
How Oracea works in the bodyDoxycycline prevents bacteria from making proteins they need to survive. It does this by blocking the molecules that attach to the ribosome of the cell, which is like a factory for making proteins. Doxycycline also stops inflammation by preventing calcium from helping create microtubules and keeping white blood cells from gathering at the site of inflammation. Additionally, it stops an enzyme that produces a molecule that causes inflammation.
When to interrupt dosage
The measure of Oracea is contingent upon the diagnosed state, including Urethritis, Chlamydia trachomatis and Respiratory Tract Infections. The dose likewise deviates in accordance with the technique of delivery (e.g. Capsule or Syrup - Oral) featured in the table underneath.Condition
Dosage
Administration
Typhus Fever
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Listeriosis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Epididymo-orchitis gonococcal
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Granuloma Inguinale
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Rickettsialpox
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Necrotizing ulcerative gingivostomatitis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
prophylaxis of Malaria
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Inclusion conjunctivitis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Tularemia
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Genus Chlamydia
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Brucellosis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Q Fever
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Acinetobacter Infections
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Uterine Cervicitis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Skin Infections
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Respiratory Tract Infections
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Severe Acne
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Actinomycosis
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Communicable Diseases
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Chlamydia Infections
75.0 mg, , 150.0 mg, 50.0 mg/mL, 100.0 mg, 25.0 mg/mL, 50.0 mg, 20.0 mg, 40.0 mg, 1.0 mg/mg, 5.0 mg/mg, 7.5 mg/mg, 80.0 mg, 8.8 %, 10.0 mg/mL, 200.0 mg, 60.0 mg, 120.0 mg, 20.0 mg/mL, 0.75 mg/mg, 0.1 mg/mg, 0.5 mg/mg, 5.0 mg/mL
Capsule, Syrup - Oral, Powder, for suspension - Oral, Capsule - Oral, Powder, for suspension, , Oral, Tablet, Capsule, delayed release pellets - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Injection, powder, lyophilized, for solution, Suspension - Oral, Gel - Oral, Kit - Oral, Intravenous, Tablet, delayed release, Syrup, Capsule, gelatin coated, Injection, powder, for solution, Tablet, delayed release - Oral, Tablet, coated - Oral, Injection, powder, lyophilized, for solution - Intravenous, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, extended release - Oral, Tablet - Oral, Powder, Oral; Topical, Injection, powder, for solution - Intravenous, Tablet, coated, Capsule - Oral; Topical, Powder - Intravenous, Capsule, extended release, For suspension - Oral, Capsule, Delayed Release, Capsule, Delayed Release - Oral, For suspension
Warnings
Oracea ContraindicationsCondition
Risk Level
Notes
Toxoplasma Infections
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Toxoplasma Infections
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Toxoplasma Infections
Common Oracea Drug Interactions
Drug Name
Risk Level
Description
Amdinocillin
Major
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Doxycycline.
Amoxicillin
Major
The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.
Ampicillin
Major
The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.
Aspoxicillin
Major
The therapeutic efficacy of Aspoxicillin can be decreased when used in combination with Doxycycline.
Azidocillin
Major
The therapeutic efficacy of Azidocillin can be decreased when used in combination with Doxycycline.
Oracea Toxicity & Overdose RiskThe lowest toxic dose of doxycycline in rats is 2000 mg/kg, 1870 mg/kg in mice, and 500 mg/kg in dogs. If someone overdoses on doxycycline, they should stop taking it and get medical help. Dialysis will not reduce the amount of drug in the body, so it will not help with an overdose.
Oracea Novel Uses: Which Conditions Have a Clinical Trial Featuring Oracea?
34 active studies are currently being conducted to assess the efficacy of Oracea in combating Haemophilus Influenzae Infections, Respiratory Tract Infections and Amebic Colitis.Condition
Clinical Trials
Trial Phases
Severe Acne
0 Actively Recruiting
Q Fever
0 Actively Recruiting
Vibrio Cholerae Infection
0 Actively Recruiting
Lymphogranuloma Venereum
0 Actively Recruiting
Chlamydia Infections
0 Actively Recruiting
Respiratory Tract Infections
1 Actively Recruiting
Phase 3
Haemophilus Influenzae Infections
0 Actively Recruiting
Calymmatobacterium granulomatis
0 Actively Recruiting
Urinary Tract Infection
11 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4
Skin Infections
3 Actively Recruiting
Phase 2, Not Applicable
Listeriosis
0 Actively Recruiting
Epididymo-orchitis gonococcal
0 Actively Recruiting
Tularemia
0 Actively Recruiting
Haemophilus ducreyi infection
0 Actively Recruiting
Typhus Fever
0 Actively Recruiting
Campylobacter Infection
1 Actively Recruiting
Phase 1
Chlamydia Infections
0 Actively Recruiting
Psittacosis
0 Actively Recruiting
Inclusion conjunctivitis
0 Actively Recruiting
Chlamydia trachomatis
1 Actively Recruiting
Phase 2
Oracea Reviews: What are patients saying about Oracea?
5Patient Review
3/14/2015 Oracea was a godsend for me. I had been struggling with Rosacea for years and tried everything to no avail. But this medication finally helped clear up my skin and I haven't had any issues since.
5Patient Review
9/26/2013 Oracea has been effective for me in clearing my face. I use it together with Finacea, and it's worked well for me. The only downside is that as soon as I try to lower the dose (at least 3 times per week), all of my bumps and pimples return. It looks like I'll have to take it for as long as I can afford it!
5Patient Review
8/15/2013 I've been using this treatment for three months now and have definitely seen an improvement. I'm less stressed in general, and when I do get stressed, the bumps aren't as bad as they used to be.
5Patient Review
10/2/2012 This drug has been a complete wonder for me, it's helped with the redness of my rosacea immensely.
4.7Patient Review
3/30/2014 I've been using this treatment for over five years to manage my Rosacea. It's been incredibly effective; however, I have to be careful about when I eat and drink (which can be annoying). All in all, though, it's a small price to pay for such good results. I haven't been able to find any information on long-term effects but, so far, so good.
4Patient Review
1/12/2012 I find this to be a very effective treatment with no notable side effects. The price is high, but there are discounts available. It can take some time to work, but it's worth being patient. In my case, it worked great and I haven't experienced any issues since stopping the treatment.
2.7Patient Review
2/2/2013 After taking Oracea and metronidazole cream as prescribed by my dermatologist, my skin started flaking off within two days. I called the doctor and they said to stop taking the metro cream. However, after reading comments online, I now realize it was the Oracea that caused the problems. I also had an outbreak on my chest and neck and terrible itching. The allergist took me off pravastatin and the redness went away along with most of the skin problems! Why don't doctors warn you about potential side effects??????
2.3Patient Review
11/20/2012 I was really excited to try this treatment because my dermatologist made it sound like a total game changer for people with Rosacea. And while I did see some improvement after taking it for a few days, it wasn't worth the awful side effects I experienced. 10% just isn't enough when the cost is so high.
2.3Patient Review
1/17/2013 I have seen zero benefits from this pill, and my acne is actually worse than before. Additionally, it was incredibly expensive; I refused to renew the prescription after learning that one month would cost over $1,000.
2Patient Review
3/31/2013 After a year of use, I haven't seen any improvement in my condition. If anything, it's gotten worse.
1.7Patient Review
2/21/2012 My rosacea symptoms actually got worse while taking this medication. I had a few initial days where it seemed to be helping, but then things took a turn for the worse. I also experienced some pretty unpleasant side effects like diarrhea, dry eyes and blurred vision, vaginal yeast infection, itching all over my body, bloating and weight gain, dizziness, and fatigue. Overall, not a great experience.
Patient Q&A Section about oracea
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.How long should you take Oracea?
"Oracea should not be used to treat or prevent infections. Its efficacy beyond 16 weeks is unknown."
Answered by AI
What is Oracea prescribed for?
"The medication ORACEA® is only effective in treating the inflammatory lesions of rosacea, not the redness. It comes in the form of capsules, each containing 40 mg of doxycycline. ORACEA is intended for use by adult patients only."
Answered by AI
Are doxycycline and Oracea the same thing?
"ORACEA® (doxycycline, USP) 40mg* Capsules contains a low dose of doxycycline, which does not work by killing bacteria like traditional antibiotic doses."
Answered by AI